Cambridge Healthtech Institute’s 17th Annual

Strategic Resource Management

Enhanced R&D Productivity, Forecasting and Planning

October 16-17, 2019


Although investment in pharma R&D continues to increase, approval of new drugs remains relatively low. This productivity crisis presents new challenges to biopharma R&D in terms of resource management, forecasting, and capacity planning. To counteract the decline in new therapeutics and high risk of product failure, biopharma must adapt with improved performance planning, intelligent outsourcing, and new big data analytics aimed at developing strategic and flexible resource management systems. Cambridge Healthtech Institute’s and the BioPharma Strategy Series’ 17th Annual Strategic Resource Management: Enhanced R&D Productivity, Forecasting and Planning attracts over 100 senior R&D executives sharing best practices and new ideas on how to enhance R&D productivity, forecasting and planning with important discussions on optimizing resource management, outsourcing, innovation, R&D, clinical capacity planning, forecasting and business intelligence strategies.

UTILIZING RESOURCE MANAGEMENT FOR BUSINESS EXCELLENCE

Forecasting Resource Requirements When There Is a New Business Strategy

Josh Kaminetz, Business Operations Lead, Strategy Realization Office, Global Regulatory Affairs and Clinical Safety, Merck

INSIGHTS-DRIVEN RESOURCE MANAGEMENT: DATA, TOOLS, ECOSYSTEMS

Scenario Modeling Analytics Using AI Machine Learning for Project and Resource Planning for Licensing-In, Acquisitions, and Business Development

Sam Mathew, MBA, Portfolio Analytics & Capacity Management Group Leader, Janssen

CO-PRESENTATION: Insights and Evolution of Amgen’s Process Development Resource Forecasting and Capacity Management Ecosystem

Cleat Jerden, Executive Director, Business Performance, Business Analysis and External Process Development, Amgen

Samantha Fairbairn, Director, Business Performance, Business Analysis and External Process Development, Amgen

CO-PRESENTATION: Time Reporting: Change Management, Business Insights, and Improved Resource Forecasting

Kathy Liu, Senior Manager, Capacity Management, Janssen

Ronnie You, Senior Manager, Capacity Management, Janssen

Research Portfolio Dynamics & Management in a Fast-Changing Biotech Setting

Benoit Schmitt, PhD, PMP, Senior Alliance & Portfolio Manager, Galapagos

RESOURCE MANAGEMENT OF TECHNICAL OPERATIONS AND CMC

Development and Implementation of a Governance Framework for a Technical Operations Organization

Michael Zachariou, PhD, Executive Director, Technical Operations CMC Product and Portfolio Management, Technical Operations, BioMarin Pharmaceuticals

Strategic Resource Management of CMC Commercialization

George Fountain III, MBA, PMP, Senior Manager, CMC Performance and Analytics, Kite Pharma, a Gilead Company

JOINT KEYNOTE SESSION: BUILDING A DATA-DRIVEN CULTURE FOR OPTIMIZED RESOURCE AND PORTFOLIO DECISION MAKING

How to Develop an After-Action Review Culture – A Guide to Incremental BUT Impactful Change Management

Michael Myers, PhD, Senior Director, LRL Due Diligence, Eli Lilly & Co.

Analytics and Culture: Lessons Learned and Comparisons between Pharma/Biotech, Oil & Gas, and Government

Timothy Nieman, Senior Manager, Portfolio Analysis, Portfolio Management Office, BioMarin Pharmaceutical


 

For more details on the conference, please contact:

Kaitlin Searfoss Kelleher

Conference Producer

Cambridge Healthtech Institute

Phone: (+1) 781-972-5498

Email: kkelleher@healthtech.com

 

For partnering and sponsorship information, please contact:
Katelin Fitzgerald

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5458

Email: kfitzgerald@healthtech.com


Register Today!

For questions about this year's event, please contact:

Kaitlin Searfoss Kelleher
Conference Producer
Cambridge Healthtech Institute
T: (+1) 781-972-5498
E: kkelleher@healthtech.com